SCHEMBL3487477

SCHEMBL3487477

CCc1ccc(Oc2ccc([N+](=O)[O-])c(CNC(=O)O)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.42
PTPN1 P18031 1/20 0.42
MEN1 O00255 6/20 0.41
USP10 Q14694 1/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
LMNA P02545 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 1/20 0.40
FFAR1 O14842 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
HPGD P15428 1/20 0.40
MAPT P10636 2/20 0.39
HTT P42858 1/20 0.39
APP P05067 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MAPK14 Q16539 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3487470 1.00 KMT2A (0.42) KMT2APTPN1MEN1USP10CRHBP
SCHEMBL3488320 0.90 FFAR1 (0.47) KMT2APTPN1MEN1CRHBPCRHR2
SCHEMBL3488317 0.90 FFAR1 (0.47) KMT2APTPN1MEN1CRHBPCRHR2
SCHEMBL3488427 0.88 PTPN1 (0.48) KMT2APTPN1MEN1CRHBPCRHR2
SCHEMBL3488422 0.88 PTPN1 (0.48) KMT2APTPN1MEN1CRHBPCRHR2
SCHEMBL3488700 0.85 KMT2A (0.44) KMT2AMEN1CRHBPCRHR2LMNA
SCHEMBL3487910 0.85 HSPB1 (0.46) KMT2AMEN1CRHBPCRHR2LMNA
SCHEMBL3488697 0.85 KMT2A (0.44) KMT2AMEN1CRHBPCRHR2LMNA
SCHEMBL3487917 0.85 HSPB1 (0.46) KMT2AMEN1CRHBPCRHR2LMNA
SCHEMBL3487468 0.82 MEN1 (0.42) KMT2AMEN1CRHBPCRHR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2138484-B1 FUSED BICYCLIC HETEROARYL DERIVATIVES DAIICHI SANKYO CO LTD (JP) 2015-08-26 EP disclosed
US-20100048564-A1 FUSED BICYCLIC HETEROARYL DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-02-25 US disclosed
EP-2138484-A1 FUSED BICYCLIC HETEROARYL DERIVATIVES Daiichi Sankyo Company, Limited (JP) 2009-12-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048564-A1 FUSED BICYCLIC HETEROARYL DERIVATIVE PPARG, GPR119, PPARA KMT2A 2465/4885PTPN1 1446/4885MEN1 4545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.